News
CYPH
0.6502
-4.06%
-0.0275
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 6d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 6d ago
Weekly Report: what happened at CYPH last week (0601-0605)?
Weekly Report · 6d ago
BUZZ-U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
Reuters · 06/05 18:02
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 06/05 17:05
BUZZ-U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
Reuters · 06/05 15:58
BUZZ-U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Reuters · 06/05 13:12
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 06/05 12:05
BUZZ-U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies
Reuters · 06/05 11:40
BUZZ-Cypherpunk Technologies slumps after crypto token Zcash plunges
Reuters · 06/05 10:21
Why Solidion Technology Shares Are Rallying Over 50%; Here Are 20 Stocks Moving Premarket
Benzinga · 06/05 10:03
Weekly Report: what happened at CYPH last week (0525-0529)?
Weekly Report · 06/01 09:34
Cypherpunk regains Nasdaq $1 minimum bid price compliance
PUBT · 05/26 12:02
Weekly Report: what happened at CYPH last week (0518-0522)?
Weekly Report · 05/25 09:35
Salesforce, Dell Headline Earnings Week Amid Light Economic Calendar
Seeking Alpha · 05/23 15:00
Weekly Report: what happened at CYPH last week (0511-0515)?
Weekly Report · 05/18 09:35
Cypherpunk Technologies GAAP EPS of -$0.46
Seeking Alpha · 05/14 11:14
Cypherpunk Technologies Q1 net loss widens
Reuters · 05/14 11:13
Cypherpunk Technologies Reports First Quarter 2026 Financial Results
PR Newswire · 05/14 11:05
Weekly Report: what happened at CYPH last week (0504-0508)?
Weekly Report · 05/11 09:34
More
Webull provides a variety of real-time CYPH stock news. You can receive the latest news about Cypherpunk Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About CYPH
Cypherpunk Technologies Inc., formerly Leap Therapeutics, Inc., is engaged in developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The Company focuses on the development of sirexatamab and FL-501 to treat patients with cancer. Zcash is a privacy-preserving blockchains, launched as a fork of Bitcoin with advanced cryptography that enables selective transparency. Zcash has introduced privacy technology through the use of zero-knowledge proofs (zk-SNARKs), allowing transactions to be verified without revealing sender, receiver, or amount. FL-501 is a potential class antibody designed to neutralize GDF-15 and prevent the binding to its receptor. sirexatamab (DKN-01), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. Sirexatamab is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.